AstraZeneca (AZN)

Sector:

Pharma and Biotech

Index:

FTSE 100

12,900.00p
   
  • Change Today:
      66.00p
  • 52 Week High: 12,940.00
  • 52 Week Low: 9,667.00
  • Currency: UK Pounds
  • Shares Issued: 1,550.71m
  • Volume: 3,180,951
  • Market Cap: £200,042m
  • RiskGrade: 123
  • Beta: 1.32

Dividends

Year End Type Amount Payment Date Ex-Div Date Record Date
31-Dec-20 Interim 59.00¢ 14-Sep-09 05-Aug-09 07-Aug-09
31-Dec-20 1st Interim 90.00¢ 14-Sep-20 13-Aug-20 14-Aug-20
  2nd Interim 190.00¢ 29-Mar-21 25-Feb-21 26-Feb-21
  Final 171.00¢ 15-Mar-10 03-Feb-10 05-Feb-10
31-Dec-21 1st Interim 90.00¢ 13-Sep-21 12-Aug-21 13-Aug-21
  2nd Interim 197.00¢ 28-Mar-22 24-Feb-22 25-Feb-22
31-Dec-22 1st Interim 93.00¢ 12-Sep-22 11-Aug-22 12-Aug-22
  2nd Interim 197.00¢ 27-Mar-23 23-Feb-23 24-Feb-23
31-Dec-23 1st Interim 93.00¢ 11-Sep-23 10-Aug-23 11-Aug-23
  2nd Interim 197.00¢ 25-Mar-24 22-Feb-24 23-Feb-24
31-Dec-24 1st Interim 100.00¢ 09-Sep-24 08-Aug-24 09-Aug-24
  2nd Interim 210.00¢ 24-Mar-25 20-Feb-25 21-Feb-25
31-Dec-25 1st Interim 103.00¢ 08-Sep-25 07-Aug-25 08-Aug-25

Note 1: Prices and trades are provided by Digital Look Corporate Solutions and are delayed by at least 15 minutes.

Note 2: RiskGrade figures are provided by RiskMetrics.

Note 3: Historical interim dividends and record dates not previously collected

Note 4: Forecast figures based on normalised accounts.

 

IFRS Changes - Find Out More

Find out about IFRS and how this affects the financial infomation for all UK companies.

AstraZeneca Market Data

Currency UK Pounds
Share Price 12,900.00p
Change Today 66.00p
% Change 0.51 %
52 Week High 12,940.00
52 Week Low 9,667.00
Volume 3,180,951
Shares Issued 1,550.71m
Market Cap £200,042m
Beta 1.32
RiskGrade 123

AstraZeneca Star Ratings

Compare performance with the sector and the market.
more star ratings
Key: vs Market vs Sector
Value
94.66% below the market average94.66% below the market average94.66% below the market average94.66% below the market average94.66% below the market average
90.24% below the sector average90.24% below the sector average90.24% below the sector average90.24% below the sector average90.24% below the sector average
Price Trend
9.16% above the market average9.16% above the market average9.16% above the market average9.16% above the market average9.16% above the market average
45.45% above the sector average45.45% above the sector average45.45% above the sector average45.45% above the sector average45.45% above the sector average
Income
68.72% below the market average68.72% below the market average68.72% below the market average68.72% below the market average68.72% below the market average
Sector averageSector averageSector averageSector averageSector average
Growth
87.64% above the market average87.64% above the market average87.64% above the market average87.64% above the market average87.64% above the market average
100.00% above the sector average100.00% above the sector average100.00% above the sector average100.00% above the sector average100.00% above the sector average

What The Brokers Say

Strong Buy 10
Buy 13
Neutral 3
Sell 0
Strong Sell 1
Total 27
buy
Broker recommendations should not be taken as investment advice, and are provided by the authorised brokers listed on this page.

AstraZeneca Dividends

  Latest Previous
  1st Interim 2nd Interim
Ex-Div 07-Aug-25 20-Feb-25
Paid 08-Sep-25 24-Mar-25
Amount 103.00¢ 210.00¢

Trades for 07-Nov-2025

Time Volume / Share Price
14:53 0 @ 12,874.00p
14:47 0 @ 12,864.00p
14:47 0 @ 12,864.00p
14:47 0 @ 12,864.00p
14:47 0 @ 12,864.00p

AstraZeneca Key Personnel

Chair Michel Demare

Top of Page